Amarantus BioScience appointed Joseph Rubinfeld to its Board of Directors

– USA,CA / SWITZERLAND,GE  – Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutic products in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, announced the appointment of Joseph Rubinfeld, Ph.D.…